Cargando…

Comment on Postma et al. Predicted Public Health and Economic Impact of Respiratory Syncytial Virus Vaccination with Variable Duration of Protection for Adults ≥60 Years in Belgium. Vaccines 2023, 11, 990

Detalles Bibliográficos
Autor principal: Standaert, Baudouin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10674508/
https://www.ncbi.nlm.nih.gov/pubmed/38005978
http://dx.doi.org/10.3390/vaccines11111646
_version_ 1785140844602327040
author Standaert, Baudouin
author_facet Standaert, Baudouin
author_sort Standaert, Baudouin
collection PubMed
description
format Online
Article
Text
id pubmed-10674508
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-106745082023-10-27 Comment on Postma et al. Predicted Public Health and Economic Impact of Respiratory Syncytial Virus Vaccination with Variable Duration of Protection for Adults ≥60 Years in Belgium. Vaccines 2023, 11, 990 Standaert, Baudouin Vaccines (Basel) Comment MDPI 2023-10-27 /pmc/articles/PMC10674508/ /pubmed/38005978 http://dx.doi.org/10.3390/vaccines11111646 Text en © 2023 by the author. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Comment
Standaert, Baudouin
Comment on Postma et al. Predicted Public Health and Economic Impact of Respiratory Syncytial Virus Vaccination with Variable Duration of Protection for Adults ≥60 Years in Belgium. Vaccines 2023, 11, 990
title Comment on Postma et al. Predicted Public Health and Economic Impact of Respiratory Syncytial Virus Vaccination with Variable Duration of Protection for Adults ≥60 Years in Belgium. Vaccines 2023, 11, 990
title_full Comment on Postma et al. Predicted Public Health and Economic Impact of Respiratory Syncytial Virus Vaccination with Variable Duration of Protection for Adults ≥60 Years in Belgium. Vaccines 2023, 11, 990
title_fullStr Comment on Postma et al. Predicted Public Health and Economic Impact of Respiratory Syncytial Virus Vaccination with Variable Duration of Protection for Adults ≥60 Years in Belgium. Vaccines 2023, 11, 990
title_full_unstemmed Comment on Postma et al. Predicted Public Health and Economic Impact of Respiratory Syncytial Virus Vaccination with Variable Duration of Protection for Adults ≥60 Years in Belgium. Vaccines 2023, 11, 990
title_short Comment on Postma et al. Predicted Public Health and Economic Impact of Respiratory Syncytial Virus Vaccination with Variable Duration of Protection for Adults ≥60 Years in Belgium. Vaccines 2023, 11, 990
title_sort comment on postma et al. predicted public health and economic impact of respiratory syncytial virus vaccination with variable duration of protection for adults ≥60 years in belgium. vaccines 2023, 11, 990
topic Comment
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10674508/
https://www.ncbi.nlm.nih.gov/pubmed/38005978
http://dx.doi.org/10.3390/vaccines11111646
work_keys_str_mv AT standaertbaudouin commentonpostmaetalpredictedpublichealthandeconomicimpactofrespiratorysyncytialvirusvaccinationwithvariabledurationofprotectionforadults60yearsinbelgiumvaccines202311990